Radioactive iodine ablation in low-risk thyroid cancer - Authors' reply. Leboulleux, S.; Borget, I.; Schlumberger, M.. Lancet Diabetes Endocrinol. 2018; 686-687: p.686-687. doi:10.1016/S2213-8587(18)30213-4ConsulterOncostatArticle